Taking progesterone supplements in the first trimester of pregnancy may not improve pregnancy outcomes for women with a history of miscarriage, according to a report published in the New England Journal of Medicine.
Recent research indicates that many pregnant women have a median urinary iodine concentration below the recommended level, which may have a negative impact on the motor and cognitive functions of offspring.
In a practice bulletin published in Obstetrics & Gynecology, recommendations are presented for the management of nausea and vomiting of pregnancy.
Iodine supplementation is potentially cost saving for pregnant women in the United Kingdom.
Results from a large birth cohort study suggest women may not be consuming enough omega-3 to meet the recommendations for pregnancy and lactation.
Church & Dwight announced the expected launch of First Response Reproductive Health Multivitamin Gummies and PreNatal & PostNatal Multivitamin Gummies, an extension of the First Response product line.
Mission Pharmacal announced the launch of CitraNatal basic, an over-the-counter (OTC) prenatal vitamin for pre-pregnancy nutritional support.
Prepregancy folate intake, particularly from supplements, is associated with a reduced risk of miscarriage and stillbirth.
TherapeuticsMD announced the launch of newly reformulated vitaMedMD RediChew Rx, a branded prescription prenatal vitamin, and Prena1 Chew, a generic prescription prenatal vitamin.
Many women of reproductive age in the United States are marginally iodine deficient, perhaps because the salt in processed foods is not iodized. Although pregnant and lactating women should take a supplement containing adequate iodide, only about 15% do so. Such supplements, however, may not contain enough iodide and may not be labeled accurately.
